Digital health innovation has accelerated in recent years, particularly with the rise of digital therapeutics (DTx) and growing evidence of their clinical benefits.
Lawmakers in the US have reintroduced legislation that aims to encourage the adoption of prescription digital therapeutics (DTx) by creating a dedicated benefit category f
A model framework for generating the evidence to demonstrate the efficacy of digital therapeutics so they can secure regulatory approval and reimbursement has been published by a trade orga
Companies trying to bring digital therapeutic (DTx) products through development and into the market have been navigating in largely uncharted waters for years.
The area of digital therapeutics is growing rapidly, and in this piece Ben Hargreaves examines why this is the case, how broadly these therapies can be applied and why investment in the are